{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:37:07Z","timestamp":1787614627420,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-025-01370-1","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:46:06Z","timestamp":1768391166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Value of albumin-bilirubin (ALBI) Grade in Patients with Gastric Cancer: A Systematic Review and meta-analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Mahyaar","family":"Omouri-Kharashtomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Ghoshouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariyan","family":"Ayati Firoozabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Mahdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Anushiravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"1","key":"1370_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12957-021-02286-3","volume":"19","author":"H Inoue","year":"2021","unstructured":"Inoue H, et al. Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer. World J Surg Oncol. 2021;19(1):173.","journal-title":"World J Surg Oncol"},{"key":"1370_CR2","first-page":"100845","volume":"41","author":"TI Mamun","year":"2024","unstructured":"Mamun TI, Younus S, Rahman MH. Gastric cancer\u2014Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review. Cancer Treat Res Commun. 2024;41:100845.","journal-title":"Cancer Treat Res Commun"},{"issue":"1","key":"1370_CR3","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1186\/s12889-024-19104-6","volume":"24","author":"J-L Lin","year":"2024","unstructured":"Lin J-L, et al. Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035. BMC Public Health. 2024;24(1):1763.","journal-title":"BMC Public Health"},{"key":"1370_CR4","doi-asserted-by":"publisher","first-page":"1463480","DOI":"10.3389\/fonc.2024.1463480","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, et al. Establishment and validation of a nomogram model for early diagnosis of gastric cancer: a large-scale cohort study. Front Oncol. 2024;14:1463480.","journal-title":"Front Oncol"},{"issue":"2","key":"1370_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.21037\/jgo-20-252","volume":"12","author":"S Fu","year":"2021","unstructured":"Fu S, et al. Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: a meta-analysis. J Gastrointest Oncol. 2021;12(2):344.","journal-title":"J Gastrointest Oncol"},{"key":"1370_CR6","doi-asserted-by":"publisher","first-page":"744839","DOI":"10.3389\/fmed.2021.744839","volume":"8","author":"Z-d Chen","year":"2021","unstructured":"Chen Z-d, et al. Recent advances in the diagnosis, staging, treatment, and prognosis of advanced gastric cancer: a literature review. Front Med. 2021;8:744839.","journal-title":"Front Med"},{"issue":"7","key":"1370_CR7","doi-asserted-by":"publisher","first-page":"e0236445","DOI":"10.1371\/journal.pone.0236445","volume":"15","author":"M-R Kim","year":"2020","unstructured":"Kim M-R, et al. Inflammatory markers for predicting overall survival in gastric cancer patients: a systematic review and meta-analysis. PLoS One. 2020;15(7):e0236445.","journal-title":"PLoS One"},{"issue":"1","key":"1370_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12957-023-02926-w","volume":"21","author":"L Yu","year":"2023","unstructured":"Yu L, et al. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer. World J Surg Oncol. 2023;21(1):50.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1370_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12911-023-02150-2","volume":"23","author":"C-M Zhou","year":"2023","unstructured":"Zhou C-M, et al. Predicting postoperative gastric cancer prognosis based on inflammatory factors and machine learning technology. BMC Med Inf Decis Mak. 2023;23(1):53.","journal-title":"BMC Med Inf Decis Mak"},{"key":"1370_CR10","doi-asserted-by":"publisher","first-page":"1408700","DOI":"10.3389\/fimmu.2024.1408700","volume":"15","author":"S Tan","year":"2024","unstructured":"Tan S, et al. Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Front Immunol. 2024;15:1408700.","journal-title":"Front Immunol"},{"issue":"6","key":"1370_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2014the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1370_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12876-025-04111-7","volume":"25","author":"J Wang","year":"2025","unstructured":"Wang J, et al. Predictive role of the Albumin-Bilirubin score in ICU patients with cirrhosis and sepsis: insights from a large retrospective cohort. BMC Gastroenterol. 2025;25(1):520.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"1370_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/MEG.0000000000001618","volume":"32","author":"L Geng","year":"2020","unstructured":"Geng L, et al. Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020;32(7):769\u201378.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"1370_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1186\/s12885-023-11488-9","volume":"23","author":"H Xu","year":"2023","unstructured":"Xu H, et al. Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):1006.","journal-title":"BMC Cancer"},{"issue":"1","key":"1370_CR15","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1038\/s41598-022-19329-8","volume":"12","author":"HG Lee","year":"2022","unstructured":"Lee HG, et al. Preoperative albumin\u2013bilirubin score as a prognostic indicator in patients with stage III colon cancer. Sci Rep. 2022;12(1):14910.","journal-title":"Sci Rep"},{"issue":"11","key":"1370_CR16","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1245\/s10434-021-09593-9","volume":"28","author":"T Imamura","year":"2021","unstructured":"Imamura T, et al. Clinical significance of preoperative Albumin\u2013Bilirubin grade in pancreatic cancer. Ann Surg Oncol. 2021;28(11):6223\u201335.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1370_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s13019-024-03311-8","volume":"19","author":"J Jiang","year":"2024","unstructured":"Jiang J, et al. Prognostic value of albumin-bilirubin grade in lung cancer: a meta-analysis. J Cardiothorac Surg. 2024;19(1):685.","journal-title":"J Cardiothorac Surg"},{"key":"1370_CR18","unstructured":"Page MJ et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021. 372."},{"key":"1370_CR19","unstructured":"Wells GA, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised\u00a0studies in meta-analyses. 2000."},{"issue":"1","key":"1370_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(1):16.","journal-title":"Trials"},{"issue":"3","key":"1370_CR21","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1245\/s10434-023-14619-5","volume":"31","author":"J Shao","year":"2024","unstructured":"Shao J, et al. Machine learning radiomics liver function model for prognostic prediction after radical resection of advanced gastric cancer: a retrospective study. Ann Surg Oncol. 2024;31(3):1749\u201359.","journal-title":"Ann Surg Oncol"},{"key":"1370_CR22","doi-asserted-by":"crossref","unstructured":"Zhu C, Wang X, Chen S, Yang X, Sun J, Pan B, et al. Efficacy of the preoperative albumin\u2013bilirubin grade for predicting survival and outcomes of postoperative chemotherapy for advanced gastric cancer.\u00a0Cancer Manag Res. 2020:11921-32.","DOI":"10.2147\/CMAR.S279782"},{"issue":"5","key":"1370_CR23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/cts.13493","volume":"16","author":"X Wang","year":"2023","unstructured":"Wang X, et al. Prognostic value of the preoperative albumin-bilirubin score among patients with stages I\u2013III gastric cancer undergoing radical resection: A retrospective study. Clin Transl Sci. 2023;16(5):850\u201360.","journal-title":"Clin Transl Sci"},{"issue":"6","key":"1370_CR24","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.4240\/wjgs.v15.i6.1125","volume":"15","author":"DJ Szor","year":"2023","unstructured":"Szor DJ, et al. Preoperative albumin-bilirubin score is a prognostic factor for gastric cancer patients after curative gastrectomy. World J Gastrointest Surg. 2023;15(6):1125.","journal-title":"World J Gastrointest Surg"},{"issue":"3","key":"1370_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.37047\/jos.2020-77649","volume":"6","author":"A K\u00dc\u00c7\u00dcKARDA","year":"2020","unstructured":"K\u00dc\u00c7\u00dcKARDA A, et al. Prognostic effect of Albumin-Bilirubin grade on survival in advance gastric cancer patients with de-novo liver metastasis. J Oncological Sci. 2020;6(3):133\u201340.","journal-title":"J Oncological Sci"},{"issue":"3","key":"1370_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00268-017-4234-x","volume":"42","author":"M Kanda","year":"2018","unstructured":"Kanda M, et al. Preoperative albumin\u2013bilirubin grade predicts recurrences after radical gastrectomy in patients with pT2-4 gastric cancer. World J Surg. 2018;42(3):773\u201381.","journal-title":"World J Surg"},{"issue":"2","key":"1370_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5230\/jgc.2019.19.e15","volume":"19","author":"T Miwa","year":"2019","unstructured":"Miwa T, Kanda M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, et al. Albumin-bilirubin score predicts tolerability to adjuvant S-1 monotherapy after curative gastrectomy. J Gastric Cancer. 2019;19(2):183.","journal-title":"J Gastric Cancer."},{"issue":"8","key":"1370_CR28","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.21873\/anticanres.15887","volume":"42","author":"M Ju","year":"2022","unstructured":"Ju M, et al. The albumin\u2013bilirubin score is a prognostic factor for gastric cancer patients who receive curative treatment. Anticancer Res. 2022;42(8):3929\u201335.","journal-title":"Anticancer Res"},{"issue":"10","key":"1370_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00595-023-02669-x","volume":"53","author":"M Shoka","year":"2023","unstructured":"Shoka M, et al. Modified albumin\u2013bilirubin grade optimized for risk stratification of patients with stage II\u2013III gastric cancer. Surg Today. 2023;53(10):1149\u201359.","journal-title":"Surg Today"},{"issue":"1","key":"1370_CR30","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1186\/s12885-024-13141-5","volume":"24","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Long-term relative survival of patients with gastric cancer from a large-scale cohort: a period-analysis. BMC Cancer. 2024;24(1):1420.","journal-title":"BMC Cancer"},{"issue":"2","key":"1370_CR31","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"10, Part B","key":"1370_CR32","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/j.ejso.2020.06.006","volume":"46","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Gong Y, Xu H. Clinical and pathological staging of gastric cancer: current perspectives and implications. Eur J Surg Oncol. 2020;46(10, Part B):e14\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"1370_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10120-018-00904-w","volume":"22","author":"J Lu","year":"2019","unstructured":"Lu J, et al. A novel TNM staging system for gastric cancer based on the metro-ticket paradigm: a comparative study with the AJCC-TNM staging system. Gastric Cancer. 2019;22(4):759\u201368.","journal-title":"Gastric Cancer"},{"issue":"7","key":"1370_CR34","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1245\/s10434-018-6447-0","volume":"25","author":"J Lu","year":"2018","unstructured":"Lu J, et al. Is the 8th edition of the AJCC TNM staging system sufficiently reasonable for all patients with noncardia gastric cancer? A 12,549-patient international database study. Ann Surg Oncol. 2018;25(7):2002\u201311.","journal-title":"Ann Surg Oncol"},{"issue":"40","key":"1370_CR35","doi-asserted-by":"publisher","first-page":"e17367","DOI":"10.1097\/MD.0000000000017367","volume":"98","author":"L Zhou","year":"2019","unstructured":"Zhou L, et al. Large tumor size is a poor prognostic factor of gastric cancer with signet ring cell: results from the surveillance, epidemiology, and end results database. Med (Baltim). 2019;98(40):e17367.","journal-title":"Med (Baltim)"},{"issue":"4","key":"1370_CR36","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.21037\/jgo-21-185","volume":"12","author":"Y-R Chen","year":"2021","unstructured":"Chen Y-R, et al. Prognostic performance of different lymph node classification systems in young gastric cancer. J Gastrointest Oncol. 2021;12(4):1285\u2013300.","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"1370_CR37","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/cancers15051628","volume":"15","author":"S Mantziari","year":"2023","unstructured":"Mantziari S, et al. A comprehensive review of prognostic factors in patients with gastric adenocarcinoma. Cancers. 2023;15(5):1628.","journal-title":"Cancers"},{"issue":"1","key":"1370_CR38","doi-asserted-by":"publisher","first-page":"107327482095445","DOI":"10.1177\/1073274820954458","volume":"27","author":"L Li","year":"2020","unstructured":"Li L, et al. A nomogram based on aspartate aminotransferase\/Alanine aminotransferase (AST\/ALT) ratio to predict prognosis after surgery in gastric cancer patients. Cancer Control. 2020;27(1):1073274820954458.","journal-title":"Cancer Control"},{"issue":"6","key":"1370_CR39","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1016\/j.ygeno.2020.08.026","volume":"112","author":"K Nie","year":"2020","unstructured":"Nie K, et al. Construction and validation of a TP53-associated immune prognostic model for gastric cancer. Genomics. 2020;112(6):4788\u201395.","journal-title":"Genomics"},{"issue":"3","key":"1370_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3892\/ol.2023.13684","volume":"25","author":"H Tanioka","year":"2023","unstructured":"Tanioka H, et al. Neutrophil\u2013to\u2013lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer. Oncol Lett. 2023;25(3):98.","journal-title":"Oncol Lett"},{"issue":"3suppl","key":"1370_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1200\/JCO.2024.42.3_suppl.397","volume":"42","author":"S Matsas","year":"2024","unstructured":"Matsas S, Junior PNA, Giglio AD. Prognostic role of platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in advanced gastric cancer treated with immunotherapy: a systematic review and meta-analysis. J Clin Oncol. 2024;42(3suppl):397\u2013397.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1370_CR42","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.21873\/invivo.11989","volume":"34","author":"T Kurosaki","year":"2020","unstructured":"Kurosaki T, et al. Glasgow prognostic score (GPS) and tumor response as biomarkers of nivolumab monotherapy in Third- or Later-line setting for advanced gastric cancer. Vivo. 2020;34(4):1921\u20139.","journal-title":"Vivo"},{"issue":"2","key":"1370_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/cc11218","volume":"16","author":"M Bernardi","year":"2012","unstructured":"Bernardi M, Maggioli C, Zaccherini G. Human albumin in the management of complications of liver cirrhosis. Crit Care. 2012;16(2):211.","journal-title":"Crit Care"},{"issue":"2","key":"1370_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1245\/s10434-006-9093-x","volume":"14","author":"LF Onate-Ocana","year":"2007","unstructured":"Onate-Ocana LF, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma: LF O\u00d1ATE-OCA\u00d1A ET AL. Ann Surg Oncol. 2007;14(2):381\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1370_CR45","doi-asserted-by":"publisher","first-page":"E437","DOI":"10.1002\/lary.26691","volume":"127","author":"WS Lim","year":"2017","unstructured":"Lim WS, et al. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma. Laryngoscope. 2017;127(12):E437\u201342.","journal-title":"Laryngoscope"},{"issue":"10","key":"1370_CR46","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/bjc.2017.313","volume":"117","author":"T K\u00fchn","year":"2017","unstructured":"K\u00fchn T, et al. Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study. Br J Cancer. 2017;117(10):1572\u20139.","journal-title":"Br J Cancer"},{"key":"1370_CR47","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S337822","author":"X Peng","year":"2021","unstructured":"Peng X, et al. Prognostic value of blood urea nitrogen to serum albumin ratio in intensive care unit patients with lung cancer. Int J Gen Med. 2021. https:\/\/doi.org\/10.2147\/IJGM.S337822.","journal-title":"Int J Gen Med"},{"issue":"4","key":"1370_CR48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3892\/ol.2020.11953","volume":"20","author":"L Zhang","year":"2020","unstructured":"Zhang L, et al. Prognostic value of fibrinogen-to-albumin ratio in patients with gastric cancer receiving first-line chemotherapy. Oncol Lett. 2020;20(4):10.","journal-title":"Oncol Lett"},{"issue":"1","key":"1370_CR49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12885-020-07191-8","volume":"20","author":"Q An","year":"2020","unstructured":"An Q, et al. Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer. BMC Cancer. 2020;20(1):691.","journal-title":"BMC Cancer"},{"issue":"29","key":"1370_CR50","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.3748\/wjg.v24.i29.3281","volume":"24","author":"W-Y Xu","year":"2018","unstructured":"Xu W-Y, et al. Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients. World J Gastroenterol. 2018;24(29):3281.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"1370_CR51","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.4251\/wjgo.v15.i9.1662","volume":"15","author":"H Sun","year":"2023","unstructured":"Sun H, et al. Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma. World J Gastrointest Oncol. 2023;15(9):1662.","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"1370_CR52","first-page":"352","volume":"2","author":"AR Guerra Ruiz","year":"2021","unstructured":"Guerra Ruiz AR, et al. Measurement and clinical usefulness of bilirubin in liver disease. Adv Lab Med. 2021;2(3):352\u201372.","journal-title":"Adv Lab Med"},{"issue":"2","key":"1370_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1053\/j.seminoncol.2014.03.006","volume":"41","author":"BI Carr","year":"2014","unstructured":"Carr BI, et al. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype. Semin Oncol. 2014;41(2):252\u20138.","journal-title":"Semin Oncol"},{"issue":"7","key":"1370_CR54","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jama.2011.124","volume":"305","author":"LJ Horsfall","year":"2011","unstructured":"Horsfall LJ, et al. Serum bilirubin and risk of respiratory disease and death. JAMA. 2011;305(7):691\u20137.","journal-title":"JAMA"},{"issue":"6","key":"1370_CR55","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1245\/s10434-022-11445-z","volume":"29","author":"H-H Koh","year":"2022","unstructured":"Koh H-H, et al. Association of albumin-bilirubin grade and myosteatosis with its prognostic significance for patients with colorectal cancer. Ann Surg Oncol. 2022;29(6):3868\u201376.","journal-title":"Ann Surg Oncol"},{"key":"1370_CR56","doi-asserted-by":"publisher","first-page":"1611175","DOI":"10.3389\/pore.2023.1611175","volume":"29","author":"L Zhang","year":"2023","unstructured":"Zhang L, et al. Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation. Pathol Oncol Res. 2023;29:1611175.","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"1370_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12876-025-03596-6","volume":"25","author":"M Omouri-Kharashtomi","year":"2025","unstructured":"Omouri-Kharashtomi M, et al. Prognostic value of albumin-bilirubin grade in patients with cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 2025;25(1):19.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"1370_CR58","first-page":"772","volume":"27","author":"Y Song","year":"2019","unstructured":"Song Y, et al. [Albumin-to-bilirubin scores for assessing the prognosis in autoimmune hepatitis-related cirrhosis]. Zhonghua Gan Zang Bing Za Zhi. 2019;27(10):772\u20136.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"8","key":"1370_CR59","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.dld.2019.01.011","volume":"51","author":"J Wang","year":"2019","unstructured":"Wang J, et al. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. Dig Liver Dis. 2019;51(8):1172\u20138.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"1370_CR60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/jvh.12638","volume":"24","author":"RC Chen","year":"2017","unstructured":"Chen RC, et al. Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis. J Viral Hepat. 2017;24(3):238\u201345.","journal-title":"J Viral Hepat"},{"issue":"7","key":"1370_CR61","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/hepr.13333","volume":"49","author":"K Fujita","year":"2019","unstructured":"Fujita K, et al. Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C. Hepatol Res. 2019;49(7):731\u201342.","journal-title":"Hepatol Res"},{"issue":"1","key":"1370_CR62","doi-asserted-by":"publisher","first-page":"17812","DOI":"10.1038\/s41598-020-74732-3","volume":"10","author":"T Ito","year":"2020","unstructured":"Ito T, et al. The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC. Sci Rep. 2020;10(1):17812.","journal-title":"Sci Rep"},{"issue":"1","key":"1370_CR63","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12872-025-04760-2","volume":"25","author":"X Gao","year":"2025","unstructured":"Gao X, et al. Association of albumin-bilirubin grade with short-and long-term mortality in patients with heart failure: a cohort study using restricted cubic splines and propensity score matching. BMC Cardiovasc Disord. 2025;25(1):307.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"1370_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-024-03543-x","volume":"25","author":"S Yang","year":"2025","unstructured":"Yang S, et al. Correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with prognosis in gastric cancer patients undergoing neoadjuvant chemotherapy: a meta-analysis. BMC Gastroenterol. 2025;25(1):1\u20139.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"1370_CR65","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12957-020-01952-2","volume":"18","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J Surg Oncol. 2020;18(1):191.","journal-title":"World J Surg Oncol"},{"key":"1370_CR66","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.2147\/OTT.S103996","volume":"9","author":"CX Zhang","year":"2016","unstructured":"Zhang CX, et al. Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis. Onco Targets Ther. 2016;9:3883\u201391.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"1370_CR67","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3892\/etm.2024.12410","volume":"27","author":"X Yang","year":"2024","unstructured":"Yang X, Wu C. Systemic immune inflammation index and gastric cancer prognosis: A systematic review and meta\u2013analysis. Exp Ther Med. 2024;27(3):122.","journal-title":"Exp Ther Med"},{"issue":"2","key":"1370_CR68","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","volume":"66","author":"DJ Pinato","year":"2017","unstructured":"Pinato DJ, et al. The ALBI grade provides objective hepatic reserve Estimation across each BCLC stage of hepatocellular carcinoma. J Hepatol. 2017;66(2):338\u201346.","journal-title":"J Hepatol"},{"issue":"5","key":"1370_CR70","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.21037\/jgo-23-599","volume":"14","author":"X Luo","year":"2023","unstructured":"Luo X, et al. High albumin-bilirubin grade predicts worse short-term complications in gastric cancer patients with metabolic syndrome: a retrospective study. J Gastrointest Oncol. 2023;14(5):2039\u201347.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"1370_CR69","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12876-023-02804-5","volume":"23","author":"H Luo","year":"2023","unstructured":"Luo H, et al. Combination of neutrophil\/lymphocyte ratio and albumin\/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy. BMC Gastroenterol. 2023;23(1):162.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"1370_CR71","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1245\/s10434-018-07125-6","volume":"26","author":"D Pereyra","year":"2019","unstructured":"Pereyra D, et al. The combination of APRI and ALBI facilitates preoperative risk stratification for patients undergoing liver surgery after neoadjuvant chemotherapy. Ann Surg Oncol. 2019;26(3):791\u20139.","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01370-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:03:54Z","timestamp":1768395834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01370-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01370-1","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"7 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a systematic review and meta-analysis, this study did not require any human participation and referral to our ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and approval and consent to participant"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13"}}